User profiles for Joel R. Lexchin
Joel LexchinProfessor Emeritus, School of Health Policy & Management, York University Verified email at yorku.ca Cited by 17877 |
Pharmaceutical research and development: what do we get for all that money?
DW Light, JR Lexchin - Bmj, 2012 - bmj.com
Data indicate that the widely touted “innovation crisis” in pharmaceuticals is a myth. The real
innovation crisis, say Donald Light and Joel Lexchin, stems from current incentives that …
innovation crisis, say Donald Light and Joel Lexchin, stems from current incentives that …
Pharmaceuticals as a market for “lemons”: Theory and practice
DW Light, JR Lexchin - Social Science & Medicine, 2021 - Elsevier
Drawing on economic theory and institutional analysis, this paper reframes Akerlof's theory
of how a market for lemons operates and argues that each of the many markets for lemons …
of how a market for lemons operates and argues that each of the many markets for lemons …
Implications of pharmaceutical industry funding on clinical research
JR Lexchin - Annals of Pharmacotherapy, 2005 - journals.sagepub.com
This commentary explores the influence of industry funding and offers suggestions for
overcoming some of the problems. First, it is difficult to obtain funding from some sources for …
overcoming some of the problems. First, it is difficult to obtain funding from some sources for …
The need to systematically evaluate clinical practice guidelines
…, L Cosgrove, JR Lexchin - The Journal of the …, 2016 - Am Board Family Med
Clinical practice guidelines abound. The recommendations contained in these guidelines
are used not only to make decisions about the care of individual patients but also as practice …
are used not only to make decisions about the care of individual patients but also as practice …
Conflicts of interest and the presence of methodologists on guideline development panels: a cross-sectional study of clinical practice guidelines for major depressive …
…, AF Shaughnessy, SM Peters, JR Lexchin… - Psychotherapy and …, 2017 - karger.com
Guidelines in many disease categories are increasingly recommending drugs as first-line
interventions for mild or subthreshold conditions, raising concerns about the quality and …
interventions for mild or subthreshold conditions, raising concerns about the quality and …
[HTML][HTML] Can reporting of adverse drug reactions create safer systems while improving health data?
Existing systems further deterred clinicians from documenting adverse drug reactions because
the systems failed to reflect the clinical processes through which adverse drug reactions …
the systems failed to reflect the clinical processes through which adverse drug reactions …
[PDF][PDF] Cost-of-living challenges highlight urgency for clinicians to prescribe affordable medications
I Gorfinkel, JR Lexchin - Canadian Family Physician, 2023 - cfp.ca
Iris Gorfinkel MDCM Joel R. Lexchin MD CCFP (EM) FCFP More than half of prescribers in
the United States use real-time prescription benefit (RTPB) technology as an add-on to …
the United States use real-time prescription benefit (RTPB) technology as an add-on to …
[PDF][PDF] From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development
…, DJ Freeman‐Coppadge, JR Lexchin - Journal of Evaluation …, 2014 - openexcellence.org
Many proponents of evidence-based medicine (EBM) call for the universal implementation
of clinical practice guidelines (CPGs). The assumption is that CPGs are trustworthy and valid, …
of clinical practice guidelines (CPGs). The assumption is that CPGs are trustworthy and valid, …
Industry involvement in clinical practice guidelines
JR Lexchin - Canadian Family Physician, 2021 - cfp.ca
Family Physician is important and we offer some comments from the United Kingdom. The
beneficial outcomes associated with continuity of family physician care are even stronger than …
beneficial outcomes associated with continuity of family physician care are even stronger than …
Engaging physicians to prescribe more cost-effectively: Blueprint for change
I Gorfinkel, A Brown, JR Lexchin - Canadian Family Physician, 2020 - cfp.ca
$ symbols indicated to physicians the cost category of the antibiotic they were prescribing.
Additionally, a link was provided to a list of antibiotics and their relative costs. The cost …
Additionally, a link was provided to a list of antibiotics and their relative costs. The cost …